Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@WorldStrokeEd Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3367350389.png) @WorldStrokeEd World Stroke Academy

World Stroke Academy posts on X about c3 the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::3367350389/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3367350389/c:line/m:interactions.svg)

- X Month XXXXX +9.40%
- X Months XXXXXX +55%
- X Year XXXXXX -XX%

### Mentions: X [#](/creator/twitter::3367350389/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3367350389/c:line/m:posts_active.svg)

- X Month X +50%
- X Months XX +67%
- X Year XX +63%

### Followers: XXXXXX [#](/creator/twitter::3367350389/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3367350389/c:line/m:followers.svg)

- X Month XXXXXX +1.10%
- X Months XXXXXX +5.80%
- X Year XXXXXX +9.90%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::3367350389/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3367350389/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::3367350389/influence)
---

**Social topic influence**
[c3](/topic/c3)
### Top Social Posts [#](/creator/twitter::3367350389/posts)
---
Top posts by engagements in the last XX hours

"#WSC2025 Dr @SposatoL on patient selection for #LAAO 🩸AF and ICH: PRAGUE-17 but no especifically studied. Guides: reasonable 😩AF and breakthroug stroke: indirect data (Protect/Prevail). WSO: C3 🔗Stroke & AF & symptomatic atherosclerotic plaque: more data needed"  
[X Link](https://x.com/WorldStrokeEd/status/1980955108188778871) [@WorldStrokeEd](/creator/x/WorldStrokeEd) 2025-10-22T11:11Z 14.5K followers, 1149 engagements


"#WSC2025 Late breaking trials #TRIDENT Intensive BP control w/ a single triple pill: telmisartan 20mg+amlodipine 2.5mg+indapamide 1.25mg for 2ry prevention after ICH 1670pts 58y 33%female 1ry outcome recurrent stroke: HR XXXX p=0.017 NNT XX 👏👏 @georgeinstitute"  
[X Link](https://x.com/WorldStrokeEd/status/1981018782794477737) [@WorldStrokeEd](/creator/x/WorldStrokeEd) 2025-10-22T15:24Z 14.5K followers, 5863 engagements


"🔥ATLAS 🧠large core stroke ✅EVT benefit in early and late window ✅EVT benefit ASPECT 0-2 and 3-5 🔴 EVT not benefit ASPECT 0-2 late window ✅ EVT benefit up to core XXX ml in early and late window"  
[X Link](https://x.com/WorldStrokeEd/status/1981024569554026625) [@WorldStrokeEd](/creator/x/WorldStrokeEd) 2025-10-22T15:47Z 14.5K followers, 4725 engagements


"🔥🔥#ATLAS coll: individual patient data X Large core RCT ✅EVT XXX% mRS 0-2 ✅EVT XX% mR 0-3 ✅EVT XX% mortality 🔴 EVT XXX% sICH #WSC2025"  
[X Link](https://x.com/WorldStrokeEd/status/1981026643499012171) [@WorldStrokeEd](/creator/x/WorldStrokeEd) 2025-10-22T15:55Z 14.5K followers, 1382 engagements


"#WSC2025 #IAT_TOP 🌐 Multicenter RCT n=246 💉 IA-tPA XXXXX mg/kg vs standard care after eTICI 2b50 in posterior AIS 🎯 mRS XX at 90d: 🟡41.9% vs XXXX% (NS) ⚠ sICH XXX% no excess risk ➡ No functional benefit of adjunct IA-tPA after EVT in PC stroke @RaulNogueiraMD"  
[X Link](https://x.com/WorldStrokeEd/status/1981740592032805291) [@WorldStrokeEd](/creator/x/WorldStrokeEd) 2025-10-24T15:12Z 14.5K followers, 1472 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@WorldStrokeEd Avatar @WorldStrokeEd World Stroke Academy

World Stroke Academy posts on X about c3 the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Month XXXXX +9.40%
  • X Months XXXXXX +55%
  • X Year XXXXXX -XX%

Mentions: X #

Mentions Line Chart

  • X Month X +50%
  • X Months XX +67%
  • X Year XX +63%

Followers: XXXXXX #

Followers Line Chart

  • X Month XXXXXX +1.10%
  • X Months XXXXXX +5.80%
  • X Year XXXXXX +9.90%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social topic influence c3

Top Social Posts #

Top posts by engagements in the last XX hours

"#WSC2025 Dr @SposatoL on patient selection for #LAAO 🩸AF and ICH: PRAGUE-17 but no especifically studied. Guides: reasonable 😩AF and breakthroug stroke: indirect data (Protect/Prevail). WSO: C3 🔗Stroke & AF & symptomatic atherosclerotic plaque: more data needed"
X Link @WorldStrokeEd 2025-10-22T11:11Z 14.5K followers, 1149 engagements

"#WSC2025 Late breaking trials #TRIDENT Intensive BP control w/ a single triple pill: telmisartan 20mg+amlodipine 2.5mg+indapamide 1.25mg for 2ry prevention after ICH 1670pts 58y 33%female 1ry outcome recurrent stroke: HR XXXX p=0.017 NNT XX 👏👏 @georgeinstitute"
X Link @WorldStrokeEd 2025-10-22T15:24Z 14.5K followers, 5863 engagements

"🔥ATLAS 🧠large core stroke ✅EVT benefit in early and late window ✅EVT benefit ASPECT 0-2 and 3-5 🔴 EVT not benefit ASPECT 0-2 late window ✅ EVT benefit up to core XXX ml in early and late window"
X Link @WorldStrokeEd 2025-10-22T15:47Z 14.5K followers, 4725 engagements

"🔥🔥#ATLAS coll: individual patient data X Large core RCT ✅EVT XXX% mRS 0-2 ✅EVT XX% mR 0-3 ✅EVT XX% mortality 🔴 EVT XXX% sICH #WSC2025"
X Link @WorldStrokeEd 2025-10-22T15:55Z 14.5K followers, 1382 engagements

"#WSC2025 #IAT_TOP 🌐 Multicenter RCT n=246 💉 IA-tPA XXXXX mg/kg vs standard care after eTICI 2b50 in posterior AIS 🎯 mRS XX at 90d: 🟡41.9% vs XXXX% (NS) ⚠ sICH XXX% no excess risk ➡ No functional benefit of adjunct IA-tPA after EVT in PC stroke @RaulNogueiraMD"
X Link @WorldStrokeEd 2025-10-24T15:12Z 14.5K followers, 1472 engagements

@WorldStrokeEd
/creator/twitter::WorldStrokeEd